Medical device manufacturerEdwards Lifesciences (EW) is down 14 percent over the past year, with shares taking a beating in recent sessions. One trader sees a potential rebound ahead in the coming weeks.
That’s based on the October $82.50 calls. With 28 days until expiration, 5,738 contracts traded compared to a prior open interest of 209, for a 27-fold rise in volume on the trade. The buyer of the calls paid $0.55 to make the bullish bet.
Edwards shares recently traded for about $72, so the stock would need to rise just over $10 per share, or over 28 percent for the option to move i...
More